Core Viewpoint - Sutra Medical, Inc. has successfully completed the first-in-man clinical trial of its Sutra Hemi-valve transcatheter mitral valve repair system, indicating a significant advancement in treating severe functional mitral regurgitation in high-risk patients [1] Company Summary - Sutra Medical, Inc. is a company in which the group holds a strategic investment [1] - The first application of the Sutra Hemi-valve system was performed on an 83-year-old high-risk patient with severe functional mitral regurgitation [1] - The procedure took place at Waikato Hospital in New Zealand, showcasing the company's international reach and clinical capabilities [1] Industry Summary - The successful implantation of the Sutra Hemi-valve system represents a potential breakthrough in the treatment options available for patients who are not suitable for traditional therapies [1] - The positive outcome of the procedure, with the patient recovering well and being discharged on the third day, highlights the effectiveness and safety of the new medical technology [1]
沛嘉医疗-B(09996)：Sutra Hemi-valve经导管二尖瓣修复系统第一次应用于人体的临床试验首例植入